Aug 26, 2020, 10:49 AM by Michael Croft

PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners

Aug 25, 2020, 15:15 PM by Michael Croft

Bio-IT World   August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Vertiv, Pure Storage, and more.

Aug 21, 2020, 21:24 PM by Michael Croft

WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the company’s executive team in the newly created role of Chief Medical Officer (CMO)

Aug 21, 2020, 09:35 AM by Michael Croft

Bio-IT World | How a beetle virus is informing SARS-CoV-2 research, plus nitrate supplementation for aid breathing, new small molecules active against the virus, and a theory for why COVID-19 patients lose their sense of smell. Plus, $9.8 million from DOD for vaccine research and virus-like particles for vaccine development.

Aug 20, 2020, 23:49 PM by Michael Croft

NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management

Aug 20, 2020, 23:36 PM by Michael Croft

NY, NY - Aug 20, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database

Aug 20, 2020, 10:41 AM by Michael Croft

MOSCOW, RUSSIA - Aug 20, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents the new version of its Immune Response Template (IRT)

Aug 20, 2020, 08:20 AM by User Not Found

Bio-IT World | In a paper published today in Nature Communications, IBM and the Broad Institute reported the first results of their collaboration to develop predictive models for cardiovascular disease.

Aug 19, 2020, 16:53 PM by Michael Croft

DURHAM, NC, US - Aug 20, 2020 - MEDIA ADVISORYRho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free WebinarCRO shares best practices and solutions to help sponsors get the most out of their hybrid, virtual and synthetic clinical trials  WHAT:                 Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will discuss its approach to and solutions for maximizing the benefits of decentralized clinical trials in an upcoming webinar, "CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials

Aug 19, 2020, 09:14 AM by Michael Croft

BOSTON, MA - Aug 19, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced a partnership with PatientPing, the nation’s most comprehensive care collaboration platform, to develop a connector solution that provides the IT infrastructure necessary to support seamless integration of e-notification data for admissions, discharges, and transfers (ADT)

Aug 18, 2020, 12:38 PM by Michael Croft

GRAND RAPIDS, MI - Aug 18, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that Ojai Valley Community Hospital’s Continuing Care Center, a brand new 75-bed skilled nursing facility, has gone live with the company’s market-leading Patient  Experience Platform and Digital Signage  solutions

Aug 18, 2020, 10:21 AM by Michael Croft

ALAMEDA, CA, UNITED STATES - Aug 18, 2020 - Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced it has appointed Julianne Averill, CPA, as Chief Financial Officer

Aug 18, 2020, 09:46 AM by Michael Croft

REDCAR, UNITED KINGDOM - Aug 18, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19

Aug 18, 2020, 09:40 AM by Michael Croft

BOSTON, MA, UNITED STATES - Aug 18, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced the availability of online scheduling for virtual care visits within its Kyruus ProviderMatch® for Consumers solution for health system websites

Aug 18, 2020, 08:35 AM by Michael Croft

Aug 18, 2020, 08:33 AM by User Not Found

Bio-IT World | New insights into the SARS-CoV-2 spike protein, a daily aerosol protectant, a look a death rates in 1918 and now, and a journal dedicated to publishing COVID-19 research with visible peer review. Plus new funding from NIH and the American Heart Association to enable further research on SARS-CoV-2 and COVID-19.

Aug 18, 2020, 06:57 AM by Michael Croft

BRISTOL, PA - Aug 18, 2020 - Cambridge, UK and San Diego, CA, 18 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania

Aug 18, 2020, 04:20 AM by Michael Croft

SHIRLEY, NY - Aug 18, 2020 - As a global Contract Research Organization (CRO), BOC Sciences has served the pharmaceutical and biotechnology industries for over a decade, and has provided an extensive catalog of amino acids, peptides and resins for laboratory and scientific applications

Aug 17, 2020, 21:59 PM by Michael Croft

SHIRLEY, NY, UNITED STATES - Aug 18, 2020 - Oncolytic viruses (OVs), evolved and engineered for cancer specificity, are gaining momentum as a new drug class in the fight against cancer

Aug 17, 2020, 14:25 PM by Michael Croft

Bio-IT World Contributed Commentary | It’s no surprise that advancements in novel technologies and the advent of big data have propelled significant breakthroughs in pharmaceutical development. The last decade has not only seen an increase in new chemical and biological entities but also significantly more innovative medicines reaching the market. Looking to the future, we also expect to see an intensified focus on neglected diseases as new and emerging biopharma companies (EBP) drive new medicine launches. However, to get there, organizations reaching for “first-in-market” status or securing key market areas depends on their ability to swiftly commercialize these new technologies and therapeutics.